These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1626940)

  • 41. [Phase II study of cisplatin in esophageal carcinoma].
    Nishihira T; Abo S; Mori S; Isono K; Endo M; Iizuka T; Fujimaki M; Sugimachi K; Kakegawa T; Kasai M
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2939-46. PubMed ID: 3767386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
    Smith JW; McIntyre KJ; Acevedo PV; Encarnacion CA; Tedesco KL; Wang Y; Asmar L; O'Shaughnessy JA
    Breast Cancer Res Treat; 2009 Nov; 118(2):361-7. PubMed ID: 19459042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
    Kimura I; Ohnoshi T; Ogawa M; Sampi K; Masaoka T; Yamada K; Ohta K; Kitani T; Kawagoe H; Shirakawa S
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2800-6. PubMed ID: 3753026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Phase I study of CI-898. CI-898 Study Group].
    Taguchi T; Tsukagoshi S; Furue H; Niitani H; Ohta K; Ariyoshi H; Hasegawa K; Majima H; Nakao I; Yasutomi M
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1599-612. PubMed ID: 1831340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.
    Plaxe SC; Blessing JA; Bookman MA; Creasman WT
    Gynecol Oncol; 2002 Jan; 84(1):32-5. PubMed ID: 11748972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Phase II study of carboplatin in cervical carcinoma].
    Noda K; Kato T; Ikeda M; Akiya K; Yajima A; Ueda G; Nishiya I; Takamizawa H; Terashima Y; Tsutsui F
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3067-72. PubMed ID: 3056277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinoma.
    Rose PG; Gordon NH; Fusco N; Fluellen L; Rodriguez M; Ingalls ST; Hoppel CL
    Gynecol Oncol; 2000 Aug; 78(2):228-34. PubMed ID: 10926808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.
    Fracasso PM; Blessing JA; Morgan MA; Sood AK; Hoffman JS
    J Clin Oncol; 2003 Aug; 21(15):2856-9. PubMed ID: 12885801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study.
    Samal B; Jones S; Brownlee RW; Morrison F; Hoogstraten B; Caoili E; Baker L
    Cancer Treat Rep; 1978 Jan; 62(1):19-22. PubMed ID: 342093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II study of cis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract. 254-S Urological Cancer Study Group.
    Akaza H; Togashi M; Nishio Y; Miki T; Kotake T; Matsumura Y; Yoshida O; Aso Y
    Cancer Chemother Pharmacol; 1992; 31(3):187-92. PubMed ID: 1334448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II trial of carboplatin in patients with advanced melanoma.
    Casper ES; Bajorin D
    Invest New Drugs; 1990 May; 8(2):187-90. PubMed ID: 1696568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Late phase II study of MST-16 (sobuzoxane) efficacy for malignant lymphoma].
    Masaoka T; Kageyama T; Tatsumi N; Akasaka K; Yonezawa T; Sugiyama H; Kitani T; Yasunaga K; Horiuchi A; Nakayama S
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):339-47. PubMed ID: 1543360
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.
    Meisner DJ; Ginsberg S; Ditch A; Louie A; Newman N; Comis R; Poiesz B
    Am J Clin Oncol; 1989 Apr; 12(2):129-31. PubMed ID: 2705402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase II study of iproplatin in advanced ovarian carcinoma.
    Sessa C; Vermorken J; Renard J; Kaye S; Smith D; ten Bokkel Huinink W; Cavalli F; Pinedo H
    J Clin Oncol; 1988 Jan; 6(1):98-105. PubMed ID: 3335895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Early phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section].
    Tominaga T; Nomura Y; Adachi I; Takashima S; Kimura M; Koyama H; Toge T; Tamura K; Hayasaka H; Kunii Y
    Gan To Kagaku Ryoho; 1994 May; 21(6):801-8. PubMed ID: 8185337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group study.
    Fabian CJ; Rasmussen S; Stephens R; Haut A; Smith F; Balcerzak S; Tranum B
    Cancer Treat Rep; 1979 Aug; 63(8):1359-61. PubMed ID: 113095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer].
    Zhu WG; Yu CH; Li T
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):525-6. PubMed ID: 22093631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.